Bain Capital Public Equity Management Ii, LLC Eli Lilly & CO Put Options Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.08 Billion
Q2 2024

Put Options

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $508,320 - $552,921	-4,760 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $527,360 - $615,563	4,760 New	4,760 $1.06 Million

Others Institutions Holding LLY

# of Institutions

3,913

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$78.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$59.5 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$53.1 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$41.4 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27.3 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $766B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account